• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫与霍奇金淋巴瘤易感性:一项基于斯堪的纳维亚人群的病例对照研究。

Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

作者信息

Landgren Ola, Engels Eric A, Pfeiffer Ruth M, Gridley Gloria, Mellemkjaer Lene, Olsen Jørgen H, Kerstann Kimberly F, Wheeler William, Hemminki Kari, Linet Martha S, Goldin Lynn R

机构信息

Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7236, USA.

出版信息

J Natl Cancer Inst. 2006 Sep 20;98(18):1321-30. doi: 10.1093/jnci/djj361.

DOI:10.1093/jnci/djj361
PMID:16985251
Abstract

BACKGROUND

Personal history of autoimmune diseases is consistently associated with increased risk of non-Hodgkin lymphoma. In contrast, there are limited data on risk of Hodgkin lymphoma following autoimmune diseases and almost no data addressing whether there is a familial association between the conditions.

METHODS

Using population-based linked registry data from Sweden and Denmark, 32 separate autoimmune and related conditions were identified from hospital diagnoses in 7476 case subjects with Hodgkin lymphoma, 18,573 matched control subjects, and more than 86,000 first-degree relatives of case and control subjects. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) as measures of relative risks for each condition using logistic regression and also applied multivariable hierarchical regression models. All P values are two-sided.

RESULTS

We found statistically significantly increased risks of Hodgkin lymphoma associated with personal histories of several autoimmune conditions, including rheumatoid arthritis (OR = 2.7, 95% CI = 1.9 to 4.0), systemic lupus erythematosus (OR = 5.8, 95% CI = 2.2 to 15.1), sarcoidosis (OR = 14.1, 95% CI = 5.4 to 36.8), and immune thrombocytopenic purpura (OR = infinity, P = .002). A statistically significant increase in risk of Hodgkin lymphoma was associated with family histories of sarcoidosis (OR = 1.8, 95% CI = 1.01 to 3.1) and ulcerative colitis (OR = 1.6, 95% CI = 1.02 to 2.6).

CONCLUSIONS

Personal or family history of certain autoimmune conditions was strongly associated with increased risk of Hodgkin lymphoma. The association between both personal and family histories of sarcoidosis and a statistically significantly increased risk of Hodgkin lymphoma suggests shared susceptibility for these conditions.

摘要

背景

自身免疫性疾病的个人病史一直与非霍奇金淋巴瘤风险增加相关。相比之下,关于自身免疫性疾病后霍奇金淋巴瘤风险的数据有限,几乎没有数据涉及这两种疾病之间是否存在家族关联。

方法

利用瑞典和丹麦基于人群的关联登记数据,从7476例霍奇金淋巴瘤病例、18573例匹配对照以及病例和对照的86000多名一级亲属的医院诊断中识别出32种单独的自身免疫性及相关疾病。我们使用逻辑回归计算每种疾病的比值比(OR)和95%置信区间(CI)作为相对风险的衡量指标,并应用多变量分层回归模型。所有P值均为双侧。

结果

我们发现,几种自身免疫性疾病的个人病史与霍奇金淋巴瘤风险在统计学上显著增加相关,包括类风湿性关节炎(OR = 2.7,95%CI = 1.9至4.0)、系统性红斑狼疮(OR = 5.8,95%CI = 2.2至15.1)、结节病(OR = 14.1,95%CI = 5.4至36.8)和免疫性血小板减少性紫癜(OR = 无穷大,P = 0.002)。结节病(OR = 1.8,95%CI = 1.01至3.1)和溃疡性结肠炎(OR = 1.6,95%CI = 1.02至2.6)的家族病史与霍奇金淋巴瘤风险在统计学上显著增加相关。

结论

某些自身免疫性疾病的个人或家族病史与霍奇金淋巴瘤风险增加密切相关。结节病的个人和家族病史与霍奇金淋巴瘤风险在统计学上显著增加之间的关联表明这些疾病存在共同易感性。

相似文献

1
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.自身免疫与霍奇金淋巴瘤易感性:一项基于斯堪的纳维亚人群的病例对照研究。
J Natl Cancer Inst. 2006 Sep 20;98(18):1321-30. doi: 10.1093/jnci/djj361.
2
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.自身免疫性和慢性炎症性疾病与非霍奇金淋巴瘤各亚型的风险
J Natl Cancer Inst. 2006 Jan 4;98(1):51-60. doi: 10.1093/jnci/djj004.
3
Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma.自身免疫性和特应性疾病与经典型霍奇金淋巴瘤的风险
Am J Epidemiol. 2015 Oct 1;182(7):624-32. doi: 10.1093/aje/kwv081. Epub 2015 Sep 6.
4
Family history of hematopoietic malignancy and risk of lymphoma.造血系统恶性肿瘤家族史与淋巴瘤风险
J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293.
5
Ultraviolet radiation exposure and risk of malignant lymphomas.紫外线辐射暴露与恶性淋巴瘤风险
J Natl Cancer Inst. 2005 Feb 2;97(3):199-209. doi: 10.1093/jnci/dji022.
6
Atopy and risk of non-Hodgkin lymphoma.特应性与非霍奇金淋巴瘤风险
J Natl Cancer Inst. 2007 Jan 17;99(2):158-66. doi: 10.1093/jnci/djk019.
7
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.个体及其近亲家庭成员中的自身免疫性疾病与非霍奇金淋巴瘤易感性
Arthritis Rheum. 2008 Mar;58(3):657-66. doi: 10.1002/art.23267.
8
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.8406例多发性骨髓瘤患者自身免疫性和血液系统疾病的家族特征:一项基于人群的病例对照研究。
Int J Cancer. 2006 Jun 15;118(12):3095-8. doi: 10.1002/ijc.21745.
9
Familial aggregation of Hodgkin lymphoma and related tumors.霍奇金淋巴瘤及相关肿瘤的家族聚集性。
Cancer. 2004 May 1;100(9):1902-8. doi: 10.1002/cncr.20189.
10
Reliability of self-reported family history of cancer in a large case-control study of lymphoma.在一项大型淋巴瘤病例对照研究中自我报告的癌症家族史的可靠性。
J Natl Cancer Inst. 2006 Jan 4;98(1):61-8. doi: 10.1093/jnci/djj005.

引用本文的文献

1
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States.美国儿童霍奇金淋巴瘤二十年发病率趋势的基于人群的分析。
Sci Rep. 2025 Jul 2;15(1):22634. doi: 10.1038/s41598-025-07472-x.
2
A Retrospective Study on the Incidence, Mortality, and Risk Factors of Hodgkin Lymphoma in Pakistan.巴基斯坦霍奇金淋巴瘤发病率、死亡率及危险因素的回顾性研究
Cureus. 2025 May 23;17(5):e84657. doi: 10.7759/cureus.84657. eCollection 2025 May.
3
Time and space co-ordinates of Hodgkin's lymphoma in Sardinia, Italy.
意大利撒丁岛霍奇金淋巴瘤的时间和空间坐标。
J Natl Cancer Cent. 2024 Jun 25;5(1):50-56. doi: 10.1016/j.jncc.2024.05.006. eCollection 2025 Feb.
4
Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study.自身免疫性疾病与淋巴瘤风险:基于真实世界数据和孟德尔随机化研究的分析
BMC Cancer. 2025 Feb 25;25(1):351. doi: 10.1186/s12885-025-13754-4.
5
Increasing incidence and prevalence of Hodgkin's lymphoma in Finland: a population-based registry study.芬兰霍奇金淋巴瘤发病率和患病率上升:一项基于人群的登记研究
Eur J Public Health. 2025 Jun 1;35(3):456-462. doi: 10.1093/eurpub/ckaf002.
6
Sarcoidosis and Cancer: The Role of the Granulomatous Reaction as a Double-Edged Sword.结节病与癌症:肉芽肿反应作为双刃剑的作用
J Clin Med. 2024 Sep 4;13(17):5232. doi: 10.3390/jcm13175232.
7
Identification and Interpretation of eQTL and eGenes for Hodgkin Lymphoma Susceptibility.鉴定和解释霍奇金淋巴瘤易感性的 eQTL 和 eGenes。
Genes (Basel). 2023 May 24;14(6):1142. doi: 10.3390/genes14061142.
8
Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review.老年强直性脊柱炎患者血液系统恶性肿瘤的风险:一项队列研究和系统评价。
Mayo Clin Proc. 2023 Jan;98(1):100-110. doi: 10.1016/j.mayocp.2022.06.030. Epub 2022 Dec 2.
9
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.填补空白:复发/难治性霍奇金淋巴瘤的免疫治疗武器库
J Clin Med. 2022 Nov 6;11(21):6574. doi: 10.3390/jcm11216574.
10
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis.霍奇金淋巴瘤的发病率、死亡率、危险因素和趋势:全球数据分析。
J Hematol Oncol. 2022 May 11;15(1):57. doi: 10.1186/s13045-022-01281-9.